• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性肿瘤所致体液性高钙血症:原发性肿瘤手术治疗期间的代谢及组织形态计量学研究

Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.

作者信息

Ralston S H, Boyce B F, Cowan R A, Gardner M D, Dryburgh F J, Boyle I T

出版信息

Q J Med. 1986 Mar;58(227):325-35.

PMID:3016790
Abstract

Several aspects of calcium metabolism were studied in five patients during the surgical exploration of malignant tumours associated with humorally-mediated hypercalcaemia. Before operation in all patients the renal tubular threshold for calcium reabsorption was raised and the threshold for renal tubular phosphate reabsorption depressed. On removal of the primary tumour in three cases, serum calcium returned to normal, renal calcium threshold fell, renal phosphate threshold rose, but urinary hydroxyproline excretion did not change. In two patients where the tumour proved inoperable, serum calcium remained elevated and no changes in renal calcium threshold or phosphate threshold occurred. Histomorphometry carried out on biopsy specimens from four patients showed normal bone resorption in three, and slightly increased resorption in one, without depression of osteoblastic bone formation. It is suggested that hypercalcaemia in these patients resulted mainly from an alteration in renal calcium threshold caused by a humoral substance released by tumour cells. Correction of hypercalcaemia on removal of the primary tumour was achieved rapidly and could be explained principally by a reduction in renal calcium threshold with increased loss of calcium into the urine. These data contrast with those of many previous studies which have emphasised the predominant role of accelerated osteoclastic bone resorption as the principal cause of hypercalcaemia in malignancy and suggest that a renal effect of the putative humoral agent may predominate in some cases.

摘要

在对五名与体液介导的高钙血症相关的恶性肿瘤患者进行手术探查期间,对钙代谢的几个方面进行了研究。在所有患者术前,肾小管对钙重吸收的阈值升高,而肾小管对磷重吸收的阈值降低。在三例患者中切除原发肿瘤后,血清钙恢复正常,肾钙阈值下降,肾磷阈值上升,但尿羟脯氨酸排泄未发生变化。在两例肿瘤无法切除的患者中,血清钙仍升高,肾钙阈值或磷阈值未发生变化。对四名患者活检标本进行的组织形态计量学检查显示,三名患者骨吸收正常,一名患者骨吸收略有增加,而成骨细胞骨形成未受抑制。提示这些患者的高钙血症主要是由肿瘤细胞释放的一种体液物质引起的肾钙阈值改变所致。切除原发肿瘤后高钙血症迅速得到纠正,这主要可通过肾钙阈值降低、尿钙丢失增加来解释。这些数据与许多先前研究的数据形成对比,那些研究强调破骨细胞骨吸收加速作为恶性肿瘤中高钙血症的主要原因的主导作用,并表明在某些情况下,假定的体液因子的肾脏效应可能占主导地位。

相似文献

1
Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.恶性肿瘤所致体液性高钙血症:原发性肿瘤手术治疗期间的代谢及组织形态计量学研究
Q J Med. 1986 Mar;58(227):325-35.
2
Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.肾细胞癌荷瘤小鼠的骨吸收和肾钙重吸收:双膦酸盐的作用
BJU Int. 2007 Jun;99(6):1530-3. doi: 10.1111/j.1464-410X.2007.06862.x. Epub 2007 Apr 8.
3
Familial benign hypercalcaemia. Study of a large family.家族性良性高钙血症。一个大家族的研究。
Q J Med. 1983 Spring;52(206):120-40.
4
Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.恶性肿瘤相关性高钙血症:高钙血症机制与降钙治疗反应之间的关系
Bone Miner. 1987 May;2(3):227-42.
5
Treatment of the hypercalcaemia of malignancy with intravenous clodronate.静脉注射氯膦酸盐治疗恶性肿瘤高钙血症
Bone. 1987;8 Suppl 1:S43-51.
6
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.体液和转移因子在恶性肿瘤高钙血症发病机制中的相对作用。
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1405-8. doi: 10.1136/bmj.288.6428.1405.
7
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.恶性肿瘤所致高钙血症:关于一种影响肾小管钙处理的非甲状旁腺体液因子的证据。
Clin Sci (Lond). 1984 Feb;66(2):187-91. doi: 10.1042/cs0660187.
8
Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy.恶性肿瘤早期和晚期体液性高钙血症患者高钙血症的不同机制
J Bone Miner Res. 1989 Feb;4(1):103-11. doi: 10.1002/jbmr.5650040115.
9
Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.血钙正常的原发性甲状旁腺功能亢进症:对甲状旁腺激素作用于肾小管钙重吸收的抵抗。
Miner Electrolyte Metab. 1984;10(5):301-8.
10
Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.甲状旁腺激素相关蛋白导致的肾钙重吸收增加是恶性肿瘤体液性高钙血症发生的一个致病因素,这种高钙血症对破骨细胞骨吸收抑制剂难治。
Clin Cancer Res. 2005 Jun 1;11(11):4198-203. doi: 10.1158/1078-0432.CCR-04-2531.

引用本文的文献

1
Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.帕米膦酸盐。其药理学特性及在溶骨性骨病中治疗效果的综述。
Drugs. 1991 Feb;41(2):289-318. doi: 10.2165/00003495-199141020-00009.